Question 1

How many institutions own SCNI stock?

Accepted Answer

A company's 13F filings with the Securities and Exchange Commission (SEC) provides investors with comprehensive information about institutional ownership in a listed company, a sign of strength in terms of how many institutions have confidence in that company. The number of institutional investors who currently own SCNI shares is 13, representing 4.29% of the company's common stock.

Question 2

Who are the major shareholders selling Scinai Immunotherapeutics Ltd. stock?

Accepted Answer

ARMISTICE CAPITAL, LLC, in the last quarter, reduced its stake in SCNI by -47.26% restricting it's holding to 121.79 thousand shares of worth nearly $63.21K. MORGAN STANLEY also lessened -0.12% of the SCNI shares from its portfolio, reducing its holding to 2.58 thousand shares of worth $1.34K. WELLS FARGO & COMPANY/MN also shunned SCNI shares holding by -100% last quarter which brought its holding to 0 shares worth -.

Question 3

Investors who are buying SCNI stock?

Accepted Answer

As per its latest 13F filing, CITADEL ADVISORS LLC increased its stake in SCNI by 100% in the last quarter. The institutional holder raised its holding to 12.21 thousand shares having worth more than $6.31K. SABBY MANAGEMENT, LLC also added 14.72% more shares of SCNI to its portfolio, raising its holding to 253.14 thousand shares of worth $131.38K. UBS GROUP AG also increased its SCNI shares holding by 0.05% which brought its holding to 2.12 thousand shares worth $1.10K.

Question 4

SCNI's major insiders: who are they?

Accepted Answer

The insider with the most stakes in SCNI is BARRON PARTNERS LP , 10 percent owner at the company. Additionally, SCNI stock is highly held by N/A N/A and N/A N/A among others.

Question 5

Did an insider recently sell SCNI stock?

Accepted Answer

Company executives, directors, and other insiders own 14.16% percent of Scinai Immunotherapeutics Ltd.'s stock. Within the last six months, there have been 0 transaction(s) in which SCNI insiders have sold stock, totaling 0 shares. Insiders that have sold shares include BARRON PARTNERS LP.

Question 6

Which insider recently purchased SCNI stock?

Accepted Answer

There have been 0 transaction(s) during the past 6-months in which Scinai Immunotherapeutics Ltd. insiders have bought stock, totalling 0 shares

Question 7

How much of SCNI does insiders own?

Accepted Answer

Around 0 Scinai Immunotherapeutics Ltd. shares are held by insiders, which represents about 14.16% of SCNI stock.

Question 8

Who is the insider with the largest stake?

Accepted Answer

SCNI 10 percent owner, BARRON PARTNERS LP holds the largest portfolio of the company's shares. SCNI shares owned by BARRON total nearly 0.

Question 9

Which institution holds the most shares in SCNI?

Accepted Answer

CITADEL ADVISORS LLC is the largest institutional owner in SCNI which holds 12.21 thousand shares worth $6.31K or 129.03% of the total SCNI shares outstanding followed by SABBY MANAGEMENT, LLC with ownership of 253.14 thousand shares representing 2,674.04% of the SCNI ownership. ARMISTICE CAPITAL, LLC is the third largest stakeholder with 121.79 thousand shares or 1,286.5% of the ownership worth more than $63.21K.

Question 10

Is Scinai Immunotherapeutics Ltd. stock optionable?

Accepted Answer

Stock options give the owner the ability but not the obligation to buy or sell a security at a predetermined price and date. Stock options can be classified into two types: puts and calls. A put is a bet on falling stock, and a call is a bet on rising stock. As far as the SCNI is concerned, it is a stock which is not optionable.

Question 11

Is there a short position on SCNI's shares?

Accepted Answer

Number of SCNI shares short is 275.35K. Shares short is a market sentiment in which investors have sold their shares short in a given stock but have not yet covered them or closed them out.

Question 12

About how many outstanding SCNI shares are there?

Accepted Answer

As of today, 999.92K shares of SCNI are outstanding.

Question 13

Is there many float in SCNI stock?

Accepted Answer

Float represents the number of tradeable shares in a specific stock. By subtracting restricted and closely-held shares from a firm's total outstanding shares, we can calculate its floating stock. The term "closely-held shares" refers to shares held by employees, major shareholders, and company insiders. At present, SCNI has 2.44B shares in float.

Question 14

SCNI short ratio: what is it?

Accepted Answer

Short ratio is calculated by dividing the number of short shares, short interest or bets that shareholders will sell short from the average daily volume. A higher ratio indicates longer times needed to repurchase borrowed shares (sold). The short ratio for SCNI is 0.1.

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2024	CITADEL ADVISORS LLC	129.03%	12.21K	6.31K	12.21K	+100.00%
Mar 31, 2024	SABBY MANAGEMENT, LLC	2,674.04%	253.14K	131.38K	32.47K	+14.72%
Mar 31, 2024	ARMISTICE CAPITAL, LLC	1,286.5%	121.79K	63.21K	-109.11K	-47.26%
Mar 31, 2024	CREDIT AGRICOLE S A	4.48%	424	193	0	0
Mar 31, 2024	MAIN STREET GROUP, LTD	2.11%	200	103	0	0
Mar 31, 2024	MORGAN STANLEY	27.24%	2.58K	1.34K	-3	-0.12%
Mar 31, 2024	UBS GROUP AG	22.37%	2.12K	1.1K	1	+0.05%
Mar 31, 2024	ASPIRE PRIVATE CAPITAL, LLC	1.69%	160	83	0	0
Mar 31, 2024	GLOBAL RETIREMENT PARTNERS, LLC	0.53%	50	26	0	0
Mar 31, 2024	QUBE RESEARCH & TECHNOLOGIES LTD	0.07%	7	4	0	0
Mar 31, 2024	WELLS FARGO & COMPANY/MN	0%	0	-	-20	-100.00%
Mar 31, 2024	MILLENNIUM MANAGEMENT LLC	112.11%	10.61K	5.48K	10.61K	+100.00%
Mar 31, 2024	RHUMBLINE ADVISERS	70.29%	6.65K	3.44K	1.34K	+25.22%

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Sep 28, 2005	BARRON PARTNERS LP	SALE	0.46	547.32K	251.77K	0
Sep 26, 2005	BARRON PARTNERS LP	SALE	0.50	5K	2.5K	547.32K
Sep 23, 2005	BARRON PARTNERS LP	SALE	0.51	5K	2.55K	552.32K

Date	Holder	% Stake	Shares Held	Total Value ($)	Shares	% Change in Portfolio
Mar 31, 2024	CITADEL ADVISORS LLC	129.03%	12.21K	6.31K	12.21K	+100.00%
Mar 31, 2024	SABBY MANAGEMENT, LLC	2,674.04%	253.14K	131.38K	32.47K	+14.72%
Mar 31, 2024	ARMISTICE CAPITAL, LLC	1,286.5%	121.79K	63.21K	-109.11K	-47.26%
Mar 31, 2024	CREDIT AGRICOLE S A	4.48%	424	193	0	0
Mar 31, 2024	MAIN STREET GROUP, LTD	2.11%	200	103	0	0
Mar 31, 2024	MORGAN STANLEY	27.24%	2.58K	1.34K	-3	-0.12%
Mar 31, 2024	UBS GROUP AG	22.37%	2.12K	1.1K	1	+0.05%
Mar 31, 2024	ASPIRE PRIVATE CAPITAL, LLC	1.69%	160	83	0	0
Mar 31, 2024	GLOBAL RETIREMENT PARTNERS, LLC	0.53%	50	26	0	0
Mar 31, 2024	QUBE RESEARCH & TECHNOLOGIES LTD	0.07%	7	4	0	0
Mar 31, 2024	WELLS FARGO & COMPANY/MN	0%	0	-	-20	-100.00%
Mar 31, 2024	MILLENNIUM MANAGEMENT LLC	112.11%	10.61K	5.48K	10.61K	+100.00%
Mar 31, 2024	RHUMBLINE ADVISERS	70.29%	6.65K	3.44K	1.34K	+25.22%

Date	Insider	Type	Cost	Shares	Value ($)	Shares Total
Sep 28, 2005	BARRON PARTNERS LP	SALE	0.46	547.32K	251.77K	0
Sep 26, 2005	BARRON PARTNERS LP	SALE	0.50	5K	2.5K	547.32K
Sep 23, 2005	BARRON PARTNERS LP	SALE	0.51	5K	2.55K	552.32K

SCNI Stock Ownership Breakdown

Scinai Immunotherapeutics

Stock Outstanding Shares

Market Insider

Institutional Ownership

Insiders

Buying/Selling by Insiders

Frequently Asked Questions